Today infertility treatments have low success rates, making the road to pregnancy painful, long, and expensive.
Fecundis improves sperm performance and gives more, better embryos.
Fecundis was founded in 2019 by reproductive scientists and infertility experts.
Infertility affects more than 100 million people worldwide.
Success rates of current assisted reproductive technologies are lower than 40%.
Treatments include high cost, stressful and invasive procedures.
Sperm function has been disregarded in clinical practice.
We are developing sperm-focused treatments to achieve better blastocysts and more pregnancies.
Our mission is to improve the success rates of assisted reproduction technologies by using precise, effective and innovative technologies, backed by a solid scientific basis.
We are an interdisciplinary team that combines scientific and business profiles.
For more information, please contact us.
We'll answer soon!
Buenos Aires - Rosario | Argentina